Chi-che Hsieh
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Nanotechnology-based reformulation of AUY922 mitigates retinal toxicity and retains potent anti-tumor activity.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: October 09, 2025
Exosome Purification Strategy Influences the Regenerative Efficacy of Dental Pulp Stem Cell-Derived Exosomes in Bone Regeneration.
Journal: Stem cell reviews and reports
Published: September 14, 2025
Suppression of STK11 induces expansion of polymorphonuclear myeloid-derived suppressive cells and activation of immune signaling in breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 31, 2025
DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer.
Journal: Oncogenesis
Published: March 22, 2024
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer.
Journal: British journal of cancer
Published: February 09, 2022
TRPM1 promotes tumor progression in acral melanoma by activating the Ca2+/CaMKIIδ/AKT pathway.
Journal: Journal of advanced research
Published: November 25, 2021
AUY922 induces retinal toxicity through attenuating TRPM1.
Journal: Journal of biomedical science
Published: February 25, 2021
The Potential of Targeting P53 and HSP90 Overcoming Acquired MAPKi-Resistant Melanoma.
Journal: Current treatment options in oncology
Published: February 20, 2019
Lymphatic vessel remodeling and invasion in pancreatic cancer progression.
Journal: EBioMedicine
Published: October 28, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026